310 related articles for article (PubMed ID: 29696669)
1. Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial.
Siaw MYL; Malone DC; Ko Y; Lee JY
J Clin Pharm Ther; 2018 Dec; 43(6):775-783. PubMed ID: 29696669
[TBL] [Abstract][Full Text] [Related]
2. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
Siaw MYL; Ko Y; Malone DC; Tsou KYK; Lew YJ; Foo D; Tan E; Chan SC; Chia A; Sinaram SS; Goh KC; Lee JY
J Clin Pharm Ther; 2017 Aug; 42(4):475-482. PubMed ID: 28449205
[TBL] [Abstract][Full Text] [Related]
3. Reducing economic burden through split-shared care model for people living with uncontrolled type 2 diabetes and polypharmacy: a multi-center randomized controlled trial.
Lum ZK; Tan JY; Wong CSM; Kok ZY; Kwek SC; Tsou KYK; Gallagher PJ; Lee JY
BMC Health Serv Res; 2024 Jun; 24(1):760. PubMed ID: 38907254
[TBL] [Abstract][Full Text] [Related]
4. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical and cost-effectiveness of collaborative care in people with uncontrolled type 2 diabetes mellitus and polypharmacy: A multicenter randomized controlled trial.
Xu Y; Tan CWY; Tsou KYK; Tan DHY; Gallagher PJ; Lee JY
Prim Care Diabetes; 2022 Feb; 16(1):188-195. PubMed ID: 34953748
[TBL] [Abstract][Full Text] [Related]
6. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial.
Warren R; Carlisle K; Mihala G; Scuffham PA
J Telemed Telecare; 2018 Oct; 24(9):586-595. PubMed ID: 28814128
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.
Simpson SH; Lier DA; Majumdar SR; Tsuyuki RT; Lewanczuk RZ; Spooner R; Johnson JA
Diabet Med; 2015 Jul; 32(7):899-906. PubMed ID: 25594919
[TBL] [Abstract][Full Text] [Related]
8. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
[TBL] [Abstract][Full Text] [Related]
9. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
10. Long-term Clinical and Cost Outcomes of a Pharmacist-managed Risk Factor Management Clinic in Singapore: An Observational Study.
Tan SH; Kng KK; Lim SM; Chan A; Loh JKK; Lee JY
Clin Ther; 2017 Dec; 39(12):2355-2365. PubMed ID: 29100730
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a multicomponent quality improvement care model for diabetes in South Asia: The CARRS randomized clinical trial.
Singh K; Kondal D; Menon VU; Varthakavi PK; Viswanathan V; Dharmalingam M; Bantwal G; Sahay RK; Masood MQ; Khadgawat R; Desai A; Prabhakaran D; Narayan KMV; Phillips VL; Tandon N; Ali MK
Diabet Med; 2023 Sep; 40(9):e15074. PubMed ID: 36815284
[TBL] [Abstract][Full Text] [Related]
12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
13. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary collaborative care in the management of patients with uncontrolled diabetes: A systematic review and meta-analysis.
Siaw MYL; Lee JY
Int J Clin Pract; 2019 Feb; 73(2):e13288. PubMed ID: 30369012
[TBL] [Abstract][Full Text] [Related]
15. A cost-effectiveness analysis of a telephone-linked care intervention for individuals with Type 2 diabetes.
Gordon LG; Bird D; Oldenburg B; Friedman RH; Russell AW; Scuffham PA
Diabetes Res Clin Pract; 2014 Apr; 104(1):103-11. PubMed ID: 24503043
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa.
Huang SJ; Galárraga O; Smith KA; Fuimaono S; McGarvey ST
Hum Resour Health; 2019 Mar; 17(1):17. PubMed ID: 30836964
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.
Chen JH; Ou HT; Lin TC; Lai EC; Kao YH
Int J Clin Pharm; 2016 Feb; 38(1):88-95. PubMed ID: 26499503
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
[TBL] [Abstract][Full Text] [Related]
19. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
Pousinho S; Morgado M; Falcão A; Alves G
J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
